zalika farmaceutica

Adar Poonawalla ‘delighted’ over Oxford-AstraZeneca-Serum vaccine’s efficacy

News

Adar Poonawalla ‘delighted’ over Oxford-AstraZeneca-Serum vaccine’s efficacy

By Zalika Famaceutica|2022-09-10T18:10:46-03:00November 24, 2020|News|

Pfizer to invest €300 million in Irish operations

News

Pfizer to invest €300 million in Irish operations

By Zalika Famaceutica|2022-09-10T18:10:47-03:00November 5, 2020|News|

Beximco Pharma wins prestigious CPhI Awards 2020

News

Beximco Pharma wins prestigious CPhI Awards 2020

By Zalika Famaceutica|2022-09-10T18:10:48-03:00October 31, 2020|News|

Some good news’: Serum CEO on trials suggesting Oxford vaccine works for all ages

News

Some good news’: Serum CEO on trials suggesting Oxford vaccine works for all ages

By Zalika Famaceutica|2022-09-10T18:10:49-03:00October 28, 2020|News|

Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

News

Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

By Zalika Famaceutica|2022-09-10T18:10:49-03:00October 23, 2020|News|

Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon

News

Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon

By Zalika Famaceutica|2022-09-10T18:10:50-03:00October 20, 2020|News|

India may get COVID-19 vaccine by March 2021: Serum Institute of India

News

India may get COVID-19 vaccine by March 2021: Serum Institute of India

By Zalika Famaceutica|2022-09-10T18:10:51-03:00October 17, 2020|News|

Novos testes rápidos de antígeno podem transformar resposta à COVID-19 nas Américas

News

Novos testes rápidos de antígeno podem transformar resposta à COVID-19 nas Américas

By Zalika Famaceutica|2022-09-10T18:10:52-03:00October 16, 2020|News|

[:en]FDA Approves Nivolumab Plus Ipilimumab for the First-Line Treatment of Unresectable Malignant Pleural Mesothelioma[:]

News

[:en]FDA Approves Nivolumab Plus Ipilimumab for the First-Line Treatment of Unresectable Malignant Pleural Mesothelioma[:]

By Zalika Famaceutica|2022-09-10T18:10:53-03:00October 6, 2020|News|

Come to Brazil with Zalika

ESCRITÓRIO REGISTRADO

Rua Turiassú, 145, Cj 121-122
Perdizes – São Paulo-SP
05005-001 – Brasil

CENTRO TÉCNICO

Rua Chopin, 33, Chácaras Reunidas Santa Terezinha
Contagem – MG
32183-150 – Brasil

GET IN TOUCH

+55 (11) 2362-0552

info@zalikafarmaceutica.com

© 2023 – All rights reserved. • Zalika Farmacêutica • Powered by Daniel